The N3RO trial: A randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants <29 weeks' gestation

بواسطة Collins, C.T, Gibson, R.A, Makrides, M, McPhee, A.J, Sullivan, T.R, Davis, P.G, Thio, M, Simmer, K, Rajadurai, V.S, Ryan, P, Morris, S, Stark, M, Travadi, J, Wright, I, Tan, K, Holberton, J, Opie, G, Callander, I, Stack, J, Shein, D, Bellhouse, S, Bolisetty, S, Lui, K, Liley, H, Berry, M, Harris, D, Chua, M.C, Agarwal, P, The N3RO Investigative Te
منشور في 2020